Fisioterapia respiratoria en pacientes con fibrosis pulmonar por Covid-19 del Hospital Teodoro Maldonado Carbo, 2021.

Abstract

Covid-19 is a disease that produces respiratory complications and one of the main sequelae associated with this virus is pulmonary fibrosis that occurs in acute and chronic phases. Pulmonary fibrosis causes a thickening in the alveolar tissue, it loses its viscoelasticity and thus prevents the normal functioning of the respiratory pump; in such a way that, the patient presents complications at the muscular level, respiratory functional capacity, and quality of life. Objective: To demonstrate the benefits of respiratory physiotherapy in patients with pulmonary fibrosis due to Covid-19 of the HTMC, in the period from June to August 2021. Methodology: We worked from a quantitative approach, explanatory in scope with an experimental design of a causal-experimental type and prospective longitudinal cutting planning. Our population consisted of 60 patients, who according to the exclusion and inclusion criteria the sample was 20 individuals. Results: The different parameters evaluated, spirometry showed low values in relation to quality of life and lung capacity, where prior intervention, 95% (n = 19) came out with a restrictive pattern and 5% (n = 1) obstructive, Significant changes are denoted in the intervention group, with normal patterns in 80% (n = 8) and restrictive in 20% (n = 2), while in the control group a restrictive pattern was presented to 100% (n = 10). Conclusion: The data indicate that the patients had improvement with respect to dyspnea, quality of life and respiratory functional capacity, therefore, they increased their autonomy.